Certifications
Transplant Hepatology
Gastroenterology
Clinical Focus
Education
MD, University of Maryland
Residency, Internal Medicine
Boston University Medical CenterFellowship, Gastroenterology
University of Virginia Health SystemFellowship, Hepatology
Mount Sinai Hospital
Awards
2005 -
Advanced Hepatology Fellowship Grant
American Association of Liver Diseases1994 -
Research and Excellence Provost's Award for Undergraduate
Johns Hopkins University, Baltimore, Maryland1994 -
Tau Beta Pi
Johns Hopkins University1991 -
Westinghouse Science Talent Search Semifinalist
Research
Research
- Portal Hypertension
- Treatment of Viral Hepatits
- Fatty Liver, NASH
Publications
Martin P, Chang C. Update on the United States Hepatitis B Treatment Algorithm. Current Hepatitis Reports 2007;.
Chang C, Singal A, Emre S, Schiano T, Lookstein R, Ganeshan S. Successful Use of Splenic Artery Embolization to Relieve Tense Ascites Following Liver Transplantation in a Patient with Budd Chiari Syndrome, Paroxysmal Nocturnal Hemoglobinuria, and Portal Vein Thrombosis: A Case Report. Liver Transplantation 2007; 13(11): 1532-1537.
Schiano T, Chang C. Drug Hepatototoxicity Update. Alimentary Pharmacology and Therapeutics 2007; 25(10): 1135-1151.
Caldwell S, Macik G, Chang C. Recombinant Activated Factor VII (rFVIIa) as a Hemostatic Agent in Liver Disease: A Break from Convention in Need of Controlled Trials. Hepatology 2004; 39(3): 592-598.
Caldwell S, Krugner-Higby L, Nakamoto R, Chang C. The Mitochondria in Non-Alcoholic Fatty Liver Disease. Clinics in Liver Disease 2004; 8(3): 595-617.
Chang C, Argo C, , Caldwell S, Al-Osaimi A. Antioxidant Therapy in Non-Alcoholic Fatty Liver Disease. J Clin Gastroenterol 2005; 39(suppl 4).
Caldwell S, Chang C, Nakamoto R, Krugner-Higby L. Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?. Clinics in Liver Disease 2004; 8(3): 595-617.
Clinical Trials
- A Phase 2, randomized, multicenter, placebo-controlled, double-blind, parallel-group study to evaluate the efficacy, safety and population PKs of once-daily oral E5501 tablets used up to 7 days in subjects with chronic liver diseases and thrombocytopenia prior to elective surgical or diagnostic procedures
- A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab and Best Supportive Care Versus Placebo and Best Supportive Care as Second-Line Treatment in Patients with Hepatocellular Carcinoma Following First-Line Therapy with Sorafenib
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Chang during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Gilead Sciences, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 4th
1425 Madison Avenue
New York, NY 10029
5 East 98th Street
12th Floor
New York, NY 10029
Fax: 212-289-7738
- Monday 8:00am - 12:00pm
- Aetna
- Beech Street
- Best Doctor
- Choice Care
- Cigna
- Group Health Insurance, Inc.
- Health Insurance Plan (HIP)
- HealthNet
- HealthPlus, Inc.
- Island Group
- Magnacare
- Medicaid
- Medicare
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Private Healthcare Systems (PHCS)
- Travel Care Services
- United Health Care Empire Plan
- United Healthcare
- Master Card
- Visa
- American Express
- Personal Check
- Cash